EXCLUSIVE: UTA has signed award-winning actress, producer, and New York Times bestselling author Lilly Singh for representation in all areas, with an eye toward helping her to secure new opportunities ...

(Reuters) -Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to discover and develop obesity drugs. The deal will give Lilly access to ...

Eli Lilly has signed a research and licence agreement with Nimbus Therapeutics, aiming to develop a new oral weight loss drug, deepening ties between the two companies. The latest partnership will see ...

STOCKHOLM, June 22, 2026 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the company has entered into a research and collaboration agreement with Eli Lilly and ...

Sept 5 (Reuters) - U.S. drugmaker Eli Lilly (LLY.N), opens new tab has signed a research deal with privately held AI-focused firm Genetic Leap to develop genetic medicines, the latter said on Thursday ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.

Sept 4 (Reuters) - Eli Lilly (LLY.N), opens new tab will license the manufacturing know-how for its rheumatoid arthritis treatment to Egypt's Eva Pharma, the companies said on Wednesday, to help ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pharma giant Eli Lilly and Co ...